Western Health Advantage
Tagrisso (osimertinib)
Drugs for Cancer : Drugs for Cancer
  • Available through Specialty Pharmacy;
  • Prior Authorization: NSCLC EGFR Mutated:
    Documented Diagnosis: Yes
    Duration: 1 year(s)

  • PA Required
  • Quantity Limit: 30 day supply per 1 fill(s).
  • NSCLC EGFR Mutated:
    Duration: 1 year(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): Oncologist
    Reauthorization Required: No
    Duration of Reauthorization: N/A